title: Advanced testicular cancer: update for urologists.
abstract: OBJECTIVE
  Testicular cancer is a model for a curable neoplasm. We review past and present accomplishments in treating testis cancer and emphasize controversial surgical issues of interest to the urologist.
  
  
  METHODS
  We reviewed early and recent chemotherapy trials of germ cell tumors, stressing random prospective phase III studies. In addition, we address specific and complicated issues that are of particular relevance for the urologist, analyzing recently published articles.
  
  
  RESULTS
  Cisplatin combination chemotherapy has dramatically improved the cure rate for patients with germ cell tumors. The indications for post-chemotherapy resection for residual masses are discussed.
  
  
  CONCLUSIONS
  The major goal 25 years ago was to develop a successful chemotherapy regimen for disseminated disease, which has now been accomplished with cisplatin combination chemotherapy. Present issues include optimal treatment in patients with poor prognostic characteristics, salvage chemotherapy strategies and indications for post-chemotherapy surgical resection.
authors.affiliation: Indiana University Medical Center, Indianapolis 46202-5289, USA.
authors.forename: L H
authors.initials: LH
authors.lastname: Einhorn
authors.forename: J P
authors.initials: JP
authors.lastname: Donohue
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D014572:Urology
chemical_list: D000970:Antineoplastic Agents